ORPHA:506136
Neuroendocrine neoplasm of esophagus
Also known as: Esophageal NEN · Esophageal neuroendocrine neoplasm · NEN of esophagus
Publications
446
84.1th percentile
Trials
1
Interventional, condition-specific
Researchers
1,335
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A group of esophageal epithelial neoplasms characterized by neuroendocrine differentiation, comprising well-differentiated neuroendocrine tumors (NETs), poorly differentiated neuroendocrine carcinomas (NECs), and mixed neuroendocrine-non-neuroendocrine neoplasms, an umbrella category including mixed adenoneuroendocrine carcinoma. The tumors typically occur in the lower esophagus, often in association with Barrett mucosa. NECs may also arise in other parts of the esophagus. On endoscopy, NETs usually appear as small polypoid or nodular submucosal masses, while NECs are large, infiltrative, and ulcerated. Patients most commonly present with dysphagia, pain, weight loss, and sometimes melena. Metastatic NETs may be associated with carcinoid syndrome.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0003649
- UMLS:C2987260
- NCIT:C95616
Additional Mondo synonyms (19)
NEN of oesophagus · esophageal NEN · esophageal NET · esophageal neuroendocrine neoplasm · esophageal neuroendocrine tumor · esophageal well differentiated endocrine tumor · esophageal well differentiated endocrine tumor/carcinoma · esophageal well differentiated endocrine tumour · esophagus NET · esophagus neuroendocrine neoplasm · esophagus neuroendocrine tumor · esophagus neuroendocrine tumor, well differentiated, low or intermediate grade · neuroendocrine neoplasm of esophagus · neuroendocrine neoplasm of oesophagus · neuroendocrine tumour of oesophagus · oesophagus NET · oesophagus neuroendocrine neoplasm · oesophagus neuroendocrine tumor, well differentiated, low or intermediate grade · oesophagus neuroendocrine tumour
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
446 matched papers (285 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
1 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
446
446 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
446 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
285 in the last 10 years · high confidence · 84.1th percentile (publications denominator)
Phrase hits: 446 · MeSH hits: 0
Who's working on it?
1,335
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Grillo F3 papers · 2026
Anatomic Pathology, Ospedale Policlinico San Martino IRCCS, Genova, Italy.
Papers in Europe PMC - 02Liu J3 papers · 2025
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University Shanghai, China.
Papers in Europe PMC - 03Zhang L3 papers · 2026
Department of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Papers in Europe PMC - 04Akiyoshi T2 papers · 2026
Department of Colorectal Surgery Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.
Papers in Europe PMC - 05Badolato R2 papers · 2022Papers in Europe PMC
- 06Baselli LA2 papers · 2022Papers in Europe PMC
- 07Cancrini C2 papers · 2022Papers in Europe PMC
- 08Carrabba M2 papers · 2022Papers in Europe PMC
- 09Chang DK2 papers · 2025
Department of Medicine, Samsung Medical Center, Seoul 06351, South Korea.
Papers in Europe PMC - 10Chen C2 papers · 2024
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting. 2 trials are registered for neoplasm of esophagus, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
1 interventional trial — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 76.8th percentile).
high confidence · 76.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Broader category: neoplasm of esophagus
2
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06070376·RECRUITING·Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.
Conditions: Esophageal Neoplasms · Dysphagia·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Neuroendocrine neoplasm of esophagus" OR "Neuroendocrine neoplasm of the esophagus" OR "Esophageal NEN" OR "Esophageal neuroendocrine neoplasm" OR "NEN of esophagus" OR "NEN of the esophagus" OR "NEN of oesophagus" OR "NEN of the oesophagus" OR "esophageal NET" OR "esophageal neuroendocrine tumor" OR "esophageal well differentiated endocrine tumor" OR "esophageal well differentiated endocrine tumor/carcinoma" OR "esophageal well differentiated endocrine tumour" OR "esophagus NET" OR "esophagus neuroendocrine neoplasm" OR "esophagus neuroendocrine tumor" OR "esophagus neuroendocrine tumor, well differentiated, low or intermediate grade" OR "neuroendocrine neoplasm of oesophagus" OR "neuroendocrine neoplasm of the oesophagus" OR "neuroendocrine tumour of oesophagus" OR "neuroendocrine tumour of the oesophagus" OR "oesophagus NET" OR "oesophagus neuroendocrine neoplasm" OR "oesophagus neuroendocrine tumor, well differentiated, low or intermediate grade" OR "oesophagus neuroendocrine tumour"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Neuroendocrine neoplasm of esophagus" OR "Neuroendocrine neoplasm of the esophagus" OR "Esophageal NEN" OR "Esophageal neuroendocrine neoplasm" OR "NEN of esophagus" OR "NEN of the esophagus" OR "NEN of oesophagus" OR "NEN of the oesophagus" OR "esophageal NET" OR "esophageal neuroendocrine tumor" OR "esophageal well differentiated endocrine tumor" OR "esophageal well differentiated endocrine tumor/carcinoma" OR "esophageal well differentiated endocrine tumour" OR "esophagus NET" OR "esophagus neuroendocrine neoplasm" OR "esophagus neuroendocrine tumor" OR "esophagus neuroendocrine tumor, well differentiated, low or intermediate grade" OR "neuroendocrine neoplasm of oesophagus" OR "neuroendocrine neoplasm of the oesophagus" OR "neuroendocrine tumour of oesophagus" OR "neuroendocrine tumour of the oesophagus" OR "oesophagus NET" OR "oesophagus neuroendocrine neoplasm" OR "oesophagus neuroendocrine tumor, well differentiated, low or intermediate grade" OR "oesophagus neuroendocrine tumour"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"neoplasm of esophagus"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T17:54:58.952Z
